Utility of magnifying endoscopy with narrow band imaging in determining the invasion depth of superficial pharyngeal cancer
-
- Daisuke Kikuchi
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Toshiro Iizuka
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Akihiro Yamada
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Tsukasa Furuhata
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Satoshi Yamashita
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Kosuke Nomura
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Yasutaka Kuribayashi
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Ryuusuke Kimura
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Akira Matsui
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Toshifumi Mitani
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Osamu Ogawa
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Hidehiko Takeda
- Department of Otorhinolaryngology Toranomon Hospital Tokyo Japan
-
- Shu Hoteya
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
-
- Mitsuru Kaise
- Department of Gastroenterology Toranomon Hospital Tokyo Japan
説明
<jats:title>ABSTRACT</jats:title><jats:sec><jats:title>Background</jats:title><jats:p>Magnifying endoscopy with narrow band imaging (ME‐NBI) is useful to diagnose invasion depth of superficial esophageal cancer. The purpose of this study was to evaluate the utility of ME‐NBI of superficial pharyngeal cancer.</jats:p></jats:sec><jats:sec><jats:title>Methods</jats:title><jats:p>Between April 2008 and June 2012, 146 lesions in 104 patients who underwent ME‐NBI and en bloc resection were retrospectively analyzed. Based on magnifying endoscopic classification, proposed by the Japan Esophageal Society, microvasculature type was classified into B1, B2, and B3.</jats:p></jats:sec><jats:sec><jats:title>Results</jats:title><jats:p>B1 alone, B2, and B3 were observed in 128, 14, and 4 lesions, respectively. The frequency of subepithelial cancer were 20.3% (26 of 128), 78.6% (11 of 14), and 100% (4 of 4), respectively (<jats:italic>p</jats:italic> < .05). Mean invasion distance were 650 μm, 720.0 μm, and 2256.5 μm. Positive and negative predictive value for diagnosing subepithelial cancer based on the presence of B2 or B3 was 83.3% (15 of 18) and 79.7% (102 of 128).</jats:p></jats:sec><jats:sec><jats:title>Conclusion</jats:title><jats:p>ME‐NBI is useful to determining invasion depth of superficial pharyngeal cancer. © 2014 Wiley Periodicals, Inc. <jats:italic>Head Neck</jats:italic> 37: 846–850, 2015</jats:p></jats:sec>
収録刊行物
-
- Head & Neck
-
Head & Neck 37 (6), 846-850, 2014-06-27
Wiley
- Tweet
キーワード
詳細情報 詳細情報について
-
- CRID
- 1362825895630711552
-
- ISSN
- 10970347
- 10433074
-
- データソース種別
-
- Crossref